|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1995-3-30
|
|
pubmed:abstractText |
To make a longitudinal study of antibodies to Klebsiella pneumoniae in patients with ankylosing spondylitis (AS) and to assess treatment effects. As a comparison we measured antibodies of 2 other gut associated bacteria, Escherichia coli and Proteus mirabilis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2082-7
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7869314-Adult,
pubmed-meshheading:7869314-Antibodies, Bacterial,
pubmed-meshheading:7869314-Double-Blind Method,
pubmed-meshheading:7869314-Escherichia coli,
pubmed-meshheading:7869314-Female,
pubmed-meshheading:7869314-Follow-Up Studies,
pubmed-meshheading:7869314-Humans,
pubmed-meshheading:7869314-Immunoblotting,
pubmed-meshheading:7869314-Immunoglobulin A,
pubmed-meshheading:7869314-Immunoglobulin G,
pubmed-meshheading:7869314-Immunoglobulin M,
pubmed-meshheading:7869314-Klebsiella pneumoniae,
pubmed-meshheading:7869314-Longitudinal Studies,
pubmed-meshheading:7869314-Male,
pubmed-meshheading:7869314-Middle Aged,
pubmed-meshheading:7869314-Proteus mirabilis,
pubmed-meshheading:7869314-Spondylitis, Ankylosing,
pubmed-meshheading:7869314-Sulfasalazine
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in ankylosing spondylitis: effect of sulfasalazine treatment.
|
|
pubmed:affiliation |
Rheumatism Foundation Hospital, Heinola, Finland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
